Model
Edge
Seres Therapeutics
0001643734
Filing Type
4
Filing Date
5/16/2024
Updated
5/17/24, 6:18 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership